Clinical Trial Update: A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma. [Phase 2]

View source ↗

Summary

A Phase 2 exploratory, single-arm multicenter trial evaluating anlotinib plus bempegaldesleukin with standard chemoradiotherapy for unresectable locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib (anlotinib)
• Bempegaldesleukin (bempegaldesleukin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Locally Advanced Soft Tissue Sarcoma | Phase 2 | Status: NOT_YET_RECRUITING